Cite

HARVARD Citation

    Elmushraf, R. et al. (n.d.). The North Trent experience of the use of first line pembrolizumab in stage IIIB/IV non-small cell lung cancer. Lung cancer. pp. S43-. [Online]. 
  
Back to record